Racial disparities in incidence of cirrhosis and extrahepatic manifestations in metabolic dysfunction-associated steatotic liver disease

被引:0
|
作者
Aboona, Majd [1 ]
Ghani, Leith [1 ]
Rangan, Pooja [1 ]
Chen, Vincent [2 ]
Ng, Cheng Han [3 ]
Huang, Daniel [4 ]
Muthiah, Mark [5 ]
Kim, Donghee [6 ]
Rubin, Moises Nevah [7 ,8 ]
Han, Ma Ai Thanda [1 ,8 ]
Fallon, Michael [1 ,8 ]
Wijarnpreecha, Karn [1 ,8 ,9 ]
机构
[1] Univ Arizona, Coll Med, Phoenix, AZ USA
[2] Univ Michigan Hlth Syst, Ann Arbor, MI USA
[3] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore
[4] Natl Univ Singapore Hosp, Singapore, Singapore
[5] Natl Univ Hlth Syst, Singapore, Singapore
[6] Stanford Univ, Sch Med, Stanford, CA USA
[7] Univ Arizona, Coll Med, Phoenix, AZ USA
[8] Banner Univ, Med Ctr, Phoenix, AZ USA
[9] Univ Arizona, BIO5 Inst, Coll Med Phoenix, Phoenix, AZ USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
FRI-236-YI
引用
收藏
页码:S478 / S478
页数:1
相关论文
共 50 条
  • [21] Menopause and metabolic dysfunction-associated steatotic liver disease
    Polyzos, Stergios A.
    Goulis, Dimitrios G.
    MATURITAS, 2024, 186
  • [22] Nutrients associated with metabolic dysfunction-associated steatotic liver disease
    Jeong, Seogsong
    JOURNAL OF HEPATOLOGY, 2024, 80 (02) : e81 - e82
  • [23] From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus
    Chen, Li
    WORLD JOURNAL OF HEPATOLOGY, 2023, 15 (12) : 1253 - 1257
  • [24] RACIAL/ETHNIC DISPARITIES IN RISKS OF CIRRHOSIS AMONG VETERANS WITH METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE IN THE UNITED STATES
    Wong, Robert
    Yang, Zeyuan
    Singal, Ashwani
    Pessoa, Mario
    Krag, Aleksander
    Schattenberg, Joern
    Henry, Linda
    Alqahtani, Saleh
    Lazarus, Jeffrey
    Younossi, Zobair
    HEPATOLOGY, 2024, 80 : S692 - S693
  • [25] Cardiovascular Risk Reduction in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis
    Bernhard, Johannes
    Galli, Lukas
    Speidl, Walter S.
    Krychtiuk, Konstantin A.
    CURRENT CARDIOLOGY REPORTS, 2025, 27 (01)
  • [26] Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician Perspective
    Eskridge, Wayne
    Cryer, Donna R.
    Schattenberg, Joern M.
    Gastaldelli, Amalia
    Malhi, Harmeet
    Allen, Alina M.
    Noureddin, Mazen
    Sanyal, Arun J.
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (19)
  • [27] RACIAL DISPARITIES IN PREVALENCE OF CIRRHOSIS AND EXTRAHEPATIC MANIFESTATIONS IN NONALCOHOLIC FATTY LIVER DISEASE
    Aboona, Majd B.
    Faulkner, Claire S.
    Rangan, Pooja
    Chen, Vincent L.
    Kim, Donghee
    Ng, Cheng Han
    Li, Fang
    Rubin, Moises I. Nevah
    Han, Ma Ai Thanda
    Fallon, Michael B.
    Wijarnpreecha, Karn
    GASTROENTEROLOGY, 2023, 164 (06) : S1308 - S1308
  • [28] Validation of FIB-4 for the diagnosis of liver cirrhosis in metabolic dysfunction-associated steatotic liver disease
    Bera, Chinmay
    Hamdan-Perez, Nashla
    Kosick, Heather Mary-Kathleen
    Shengir, Mohamed
    Sebastiani, Giada
    Patel, Keyur
    CANADIAN LIVER JOURNAL, 2025, 0 (AOP):
  • [29] Molecular pathogenesis of metabolic dysfunction-associated steatotic liver disease, steatohepatitis, hepatic fibrosis and liver cirrhosis
    Saito, Takashi
    Tsuchishima, Mutsumi
    Tsutsumi, Mikihiro
    George, Joseph
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (12)
  • [30] Psychosocial risks in metabolic dysfunction-associated steatotic liver disease
    Astrom, Hanne
    Takami Lageborn, Christine
    Hagstrom, Hannes
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2025, 19 (03) : 273 - 290